← Back to headlines
Dyne Therapeutics Stock Slips After Upsized $375M Public Offering
Dyne Therapeutics' stock slipped after the company priced an upsized $375 million public offering at $20.50 per share, following an earlier announcement of a $300 million stock offering that led to a 14% drop in shares.
22 Jul, 06:45 — 22 Jul, 06:45
Sources
Showing 1 of 1 sources
Related Stories
Greek Minister Kikilias Attends 9th Trilateral Maritime Meeting in Cyprus
30m ago
Safe Bulkers Shares Drop on $12M Private Placement for New Vessels
31m ago
Volkswagen Explores Strategic Partnership With JSW Group to Boost Indian Market Share
36m ago
Cyprus Records EU's Lowest Suicide Rate as Labour Productivity Rises
43m ago